Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence

RNA Biology

Volumn 6, Issue 3, 2009, Pages 305-315

  Andersen, Jesper B ^a   Mazan Mamczarz, Krystyna ^b   Zhan, Ming ^b   Gorospe, Myriam ^b   Hassel, Bret A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

2 5 oligoadenylate; mRNA stability; Ribosomal protein; RNase L; Senescence

Indexed keywords

MESSENGER RNA; RIBONUCLEASE L; RIBOSOME PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROTEIN SYNTHESIS; RNA DEGRADATION; RNA STRUCTURE; SENESCENCE; SEQUENCE ANALYSIS;

EID: 67650472415     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.6.3.8526     Document Type: Article

References (54)

1. Silverman RH. A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev 2007; 18:381-388 (Pubitemid 47302833)
2. Baglioni C, De Benedetti A, Williams GJ. Cleavage of nascent reovirus mRNA by localized activation of the 2′-5′-oligoadenylate-dependent endoribonuclease. J Virol 1984; 52:865-871 (Pubitemid 15216312)
3. Li XL, Blackford JA, Hassel BA. RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J Virol 1998; 72:2752-2759 (Pubitemid 28175511)
4. Bisbal C, Silhol M, Laubenthal H, Kaluza T, Carnac G, Milligan L, Le Roy F, Salehzada T. The 2′-5′ oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol Cell Biol 2000; 20:4959-4969 (Pubitemid 30431550)
5. Li XL, Blackford JA, Judge CS, Liu M, Xiao W, Kalvakolanu DV, Hassel BA. RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J Biol Chem 2000; 275:8880-8888 (Pubitemid 30180244)
6. Khabar KS, Siddiqui YM, al-Zoghaibi F, al-Haj L, Dhalla M, Zhou A, et al. RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR. J Biol Chem 2003; 278:20124-20132
7. Chandrasekaran K, Mehrabian Z, Li XL, Hassel B. RNase-L regulates the stability of mitochondrial DNA-encoded mRNAs in mouse embryo fibroblasts. Biochem Biophys Res Commun 2004; 325:18-23. (Pubitemid 39441155)
8. Silverman RH, Skehel JJ, James TC, Wreschner DH, Kerr IM. rRNA cleavage as an index of ppp(A2′p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J Virol 1983; 46:1051-1055
9. Wreschner DH, James TC, Silverman RH, Kerr IM. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res 1981; 9:1571-1581 (Pubitemid 11002216)
10. Floyd-Smith G, Slattery E, Lengyel P. Interferon action: RNA cleavage pattern of a (2′-5′) oligoadenylate - dependent endonuclease. Science 1981; 212:1030-1032 (Pubitemid 11078012)
11. Wreschner DH, McCauley JW, Skehel JJ, Kerr IM. Interferon action - sequence specificity of the ppp(A2′p)nA-dependent ribonuclease. Nature 1981; 289:414-417 (Pubitemid 11135153)
12. Silverman RH, Jung DD, Nolan-Sorden NL, Dieffenbach CW, Kedar VP, SenGupta DN. Purification and analysis of murine 2-5A-dependent RNase. J Biol Chem 1988; 263:7336-7341
13. Zhou A, Hassel BA, Silverman RH. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 1993; 72:753-765 (Pubitemid 23093883)
14. Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC, et al. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 1997; 186:967-972 (Pubitemid 27407357)
15. Diaz-Guerra M, Rivas C, Esteban M. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 1997; 236:354-363 (Pubitemid 27423778)
16. Kubota K, Nakahara K, Ohtsuka T, Yoshida S, Kawaguchi J, Fujita Y, et al. Identification of 2′-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon. J Biol Chem 2004; 279:37832-37841 (Pubitemid 39195498)
17. 32P-labelled derivatives of ppp(A2′p)nA. Eur J Biochem 1981; 115:79-85.
18. Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T. Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway. J Biol Chem 1995; 270:13308-13317
19. Chase BI, Zhou Y, Xiang Y, Silverman RH, Zhou A. Proteasome-mediated degradation of RNase L in response to phorbol-12-myristate-13-acetate (PMA) treatment of mouse L929 cells. J Interferon Cytokine Res 2003; 23:565-573 (Pubitemid 37323678)
20. Williams BR, Golgher RR, Brown RE, Gilbert CS, Kerr IM. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature 1979; 282:582-586 (Pubitemid 10213914)
21. Thakur CS, Jha BK, Dong B, Das Gupta J, Silverman KM, Mao H, et al. Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc Natl Acad Sci USA 2007; 104:9585-9590 (Pubitemid 47175310)
22. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 1993; 12:3297-3304 (Pubitemid 23232761)
23. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′- oligoadenylate-dependent RNase L. EMBO J 1997; 16:6355-6363 (Pubitemid 27483262)
24. Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, Shelby S, et al. Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene 2006.
25. Campisi J. Senescent cells, tumor suppression and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-522 (Pubitemid 40269765)
26. Schmitt CA. Senescence, apoptosis and therapy - cutting the lifelines of cancer. Nat Rev Cancer 2003; 3:286-295 (Pubitemid 37328864)
27. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004; 23:2919-2933 (Pubitemid 38638853)
28. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002; 30:181-184 (Pubitemid 34887712)
29. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 2002; 32:581-583 (Pubitemid 35435169)
30. Liu W, Liang SL, Liu H, Silverman R, Zhou A. Tumour suppressor function of RNase L in a mouse model. Eur J Cancer 2007; 43:202-209 (Pubitemid 46054467)
31. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 2007; 104:1655-1660 (Pubitemid 46214646)
32. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006; 2:25.
33. Seshadri T, Uzman JA, Oshima J, Campisi J. Identification of a transcript that is down-regulated in senescent human fibroblasts. Cloning, sequence analysis, and regulation of the human L7 ribosomal protein gene. J Biol Chem 1993; 268:18474-18480 (Pubitemid 23273776)
34. Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn 2003; 5:73-81. (Pubitemid 36553428)
35. Malathi K, Paranjape JM, Bulanova E, Shim M, Guenther-Johnson JM, Faber PW, et al. A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L. Proc Natl Acad Sci USA 2005; 102:14533-14538 (Pubitemid 41457092)
36. Le Roy F, Salehzada T, Bisbal C, Dougherty JP, Peltz SW. A newly discovered function for RNase L in regulating translation termination. Nat Struct Mol Biol 2005; 12:505-512 (Pubitemid 43085880)
37. Baglioni C, D'Alessandro SB, Nilsen TW, den Hartog JA, Crea R, van Boom JH. Analogs of (2′-5′)oligo(A). Endonuclease activation and inhibition of protein synthesis in intact cells. J Biol Chem 1981; 256:3253-3257 (Pubitemid 11076982)
38. Washenberger CL, Han JQ, Kechris KJ, Jha BK, Silverman RH, Barton DJ. Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. Virus research 2007; 130:85-95. (Pubitemid 350051094)
39. Lopez de Silanes I, Galban S, Martindale JL, Yang X, Mazan-Mamczarz K, Indig FE, et al. Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol Cell Biol 2005; 25:9520-9531 (Pubitemid 41507852)
40. Mayer C, Grummt I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 2006; 25:6384-6391 (Pubitemid 44582283)
41. Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 2007; 8:533-543 (Pubitemid 46955210)
42. Hamilton TL, Stoneley M, Spriggs KA, Bushell M. TOPs and their regulation. Biochemical Society transactions 2006; 34:12-16
43. Nilsen TW, Baglioni C. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc Natl Acad Sci USA 1979; 76:2600-2604 (Pubitemid 9213915)
44. Molinaro RJ, Jha BK, Malathi K, Varambally S, Chinnaiyan AM, Silverman RH. Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res 2006; 34:6684-6695 (Pubitemid 46017960)
45. Han JQ, Townsend HL, Jha BK, Paranjape JM, Silverman RH, Barton DJ. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. J Virol 2007; 81:5561-5572 (Pubitemid 46846996)
46. Abdelmohsen K, Kuwano Y, Kim HH, Gorospe M. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biological chemistry 2008; 389:243-255 (Pubitemid 351329020)
47. Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat Med 2004; 10:484-6.
48. Groisman I, Ivshina M, Marin V, Kennedy NJ, Davis RJ, Richter JD. Control of cellular senescence by CPEB. Genes Dev 2006; 20:2701-2712
49. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-408 (Pubitemid 34164012)
50. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genomewide expression patterns. Proc Natl Acad Sci USA 1998; 95:14863-14868 (Pubitemid 29003722)
51. Li XL, Andersen JB, Ezelle HJ, Wilson GM, Hassel BA. Post-transcriptional regulation of RNase-L expression is mediated by the 3′untranslated region of its mRNA. J Biol Chem 2007. (Pubitemid 47093551)
52. Dong B, Silverman RH. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 1995; 270:4133-4137
53. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35:169-175
54. Lopez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 2004; 101:2987-2992 (Pubitemid 38327723)